Preoperative coronary revascularization in high-risk patients undergoing vascular surgery: A core review

Anesthesia and Analgesia

Volumn 106, Issue 3, 2008, Pages 751-758

  Kertai, Miklos D ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; BLEEDING; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; THROMBOSIS; VASCULAR SURGERY;

EID: 39749190717     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31816072b3     Document Type: Review

References (42)

1. KA Eagle PB Berger H Calkins BR Chaitman GA Ewy KE Fleischmann LA Fleisher JB Froehlich RJ Gusberg JA Leppo T Ryan RC Schlant WL Winters Jr RJ Gibbons EM Antman JS Alpert DP Faxon V Fuster G Gregoratos AK Jacobs LF Hiratzka RO Russell SC Smith Jr ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation 105 2002 1257 1267
2. NR Hertzer EG Beven JR Young PJ O'Hara WF Ruschhaupt 3rd RA Graor VG Dewolfe LC Maljovec Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management Ann Surg 199 1984 223 233
3. NR Hertzer JR Young EG Beven PJ O'Hara RA Graor WF Ruschhaupt LC Maljovec Late results of coronary bypass in patients with infrarenal aortic aneurysms. The Cleveland Clinic Study Ann Surg 205 1987 360 367
4. NR Hertzer JR Young EG Beven PJ O'Hara RA Graor WF Ruschhaupt LC Maljovec Late results of coronary bypass in patients presenting with lower extremity ischemia: the Cleveland Clinic Study Ann Vasc Surg 1 1987 411 419
5. KA Eagle CS Rihal MC Mickel DR Holmes ED Foster BJ Gersh Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study Circulation 96 1997 1882 1887
6. LA Fleisher KA Eagle T Shaffer GF Anderson Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the medicare population Anesth Analg 89 1999 849 855
7. SA Hassan MA Hlatky DB Boothroyd C Winston DB Mark MM Brooks KA Eagle Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI) Am J Med 110 2001 260 266
8. MR Back N Stordahl D Cuthbertson BL Johnson DF Bandyk Limitations in the cardiac risk reduction provided by coronary revascularization prior to elective vascular surgery J Vasc Surg 36 2002 526 533
9. G Landesberg M Mosseri YG Wolf M Bocher A Basevitch E Rudis U Izhar H Anner C Weissman Y Berlatzky Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery Circulation 108 2003 177 183
10. G Landesberg Y Berlatzky M Bocher R Alcalai H Anner T Ganon-Rozental MH Luria I Akopnik C Weissman M Mosseri A clinical survival score predicts the likelihood to benefit from preoperative thallium scanning and coronary revascularization before major vascular surgery Eur Heart J 2006 533 539
11. DT Mangano EL Layug A Wallace I Tateo Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of Perioperative Ischemia Research Group N Engl J Med 335 1996 1713 1720
12. D Poldermans E Boersma JJ Bax IR Thomson LL van de Ven JD Blankensteijn HF Baars TI Yo G Trocino C Vigna JR Roelandt H van Urk The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group N Engl J Med 341 1999 1789 1794
13. PK Lindenauer P Pekow K Wang DK Mamidi B Gutierrez EM Benjamin Perioperative beta-blocker therapy and mortality after major noncardiac surgery N Engl J Med 353 2005 349 361
14. PK Lindenauer P Pekow K Wang B Gutierrez EM Benjamin Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery JAMA 291 2004 2092 2099
15. D Poldermans JJ Bax MD Kertai B Krenning CM Westerhout AF Schinkel IR Thomson PJ Lansberg LA Fleisher J Klein H van Urk JR Roelandt E Boersma Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 2003 1848 1851
16. CS Rihal K Sutton-Tyrrell P Guo NM Keller R Jandova MA Sellers HV Schaff DR Holmes Jr Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the Bypass Angioplasty Revascularization Investigation Circulation 100 1999 171 177
17. JR Allen TS Helling GO Hartzler Operative procedures not involving the heart after percutaneous transluminal coronary angioplasty Surg Gynecol Obstet 173 1991 285 288
18. JR Elmore JW Hallett Jr RJ Gibbons JM Naessens TC Bower KJ Cherry P Gloviczki PC Pairolero Myocardial revascularization before abdominal aortic aneurysmorrhaphy: effect of coronary angioplasty Mayo Clin Proc 68 1993 637 641
19. A Gottlieb M Banoub J Sprung PJ Levy M Beven EJ Mascha Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty J Cardiothorac Vasc Anesth 12 1998 501 506
20. KL Posner GA Van Norman V Chan Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty Anesth Analg 89 1999 553 560
21. G Godet B Riou M Bertrand MH Fléron JP Goarin G Montalescot P Coriat Does preoperative coronary angioplasty improve perioperative cardiac outcome? Anesthesiology 102 2005 739 746
22. GL Kaluza J Joseph JR Lee ME Raizner AE Raizner Catastrophic outcomes of noncardiac surgery soon after coronary stenting J Am Coll Cardiol 35 2000 1288 1294
23. SH Wilson P Fasseas JL Orford RJ Lennon T Horlocker NE Charnoff S Melby PB Berger Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting J Am Coll Cardiol 42 2003 234 240
24. PR Reddy PT Vaitkus Risks of noncardiac surgery after coronary stenting Am J Cardiol 95 2005 755 757
25. O Schouten RT van Domburg JJ Bax PJ de Jaegere M Dunkelgrun HH Feringa SE Hoeks D Poldermans Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events J Am Coll Cardiol 49 2007 122 125
26. EO McFalls HB Ward TE Moritz S Goldman WC Krupski F Littooy G Pierpont S Santilli J Rapp B Hattler K Shunk C Jaenicke L Thottapurathu N Ellis DJ Reda WG Henderson Coronary-artery revascularization before elective major vascular surgery N Engl J Med 351 2004 2795 2804
27. HB Ward RF Kelly L Thottapurathu TE Moritz GC Larsen G Pierpont S Santilli S Goldman WC Krupski F Littooy DJ Reda EO McFalls Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery Ann Thorac Surg 82 2006 795 801
28. A Raghunathan JH Rapp F Littooy S Santilli WC Krupski HB Ward L Thottapurathu T Moritz EO McFalls CARP Investigators Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial J Vasc Surg 43 2006 1175 1182
29. D Poldermans O Schouten R Vidakovic AN Neskovic B Paelinck G Rocci L van Dortmont AE Durazzo LL van de Ven MR van Sambeek MD Kertai E Boersma Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery J Am Coll Cardiol 49 2007 1763 1769
30. E Boersma D Poldermans JJ Bax EW Steyerberg IR Thomson JD Banga LL van De Ven H van Urk JR Roelandt DECREASE Study Group (Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography) Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy JAMA 285 2001 1865 1873
31. JD Blankensteijn SECA de Jong M Prinssen AC van der Ham J Buth SM van Sterkenburg HJ Verhagen E Buskens DE Grobbee Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms N Engl J Med 352 2005 2398 2405
32. LH Opie PJ Commerford BJ Gersh Controversies in stable coronary artery disease Lancet 367 2006 69 78
33. SN Hoffman JA TenBrook MP Wolf SG Pauker DN Salem JB Wong A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes J Am Coll Cardiol 41 2003 1293 1304
34. CS Rihal D Raco BJ Gersh S Yusuf Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina Circulation 108 2003 2439 2445
35. The BARI Investigators The final 10-year folow-up. Results from the BARI randomized trial J Am Coll Cardiol 49 2007 1600 1606
36. DG Katritsis JP Ioannidis Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis Circulation 111 2005 2906 2912
37. WE Boden RA O'Rourke KK Teo PM Hartigan DJ Maron WJ Kostuk M Knudtson M Dada P Casperson CL Harris BR Chaitman L Shaw G Gosselin S Nawaz LM Title G Gau AS Blaustein DC Booth ER Bates JA Spertus DS Berman GB Mancini WS Weintraub COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1 14
38. C Kaiser HP Brunner-La Rocca PT Buser PO Bonetti S Osswald A Linka A Bernheim A Zutter M Zellweger L Grize ME Pfisterer BASKET Investigators Incremental costeffectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET) Lancet 366 2005 921 929
39. DE Cutlip AG Chhabra DS Baim MS Chauhan S Marulkar J Massaro A Bakhai DJ Cohen RE Kuntz KK Ho Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials Circulation 110 2004 1226 1230
40. BJ Gersh RL Frye Methods of coronary revascularization-things may not be as they seem N Engl J Med 352 2005 2235 2237
41. J Saw DL Bhatt DJ Moliterno SJ Brener SR Steinhubl AM Lincoff JE Tcheng RA Harrington M Simoons T Hu MA Sheikh DJ Kereiakes EJ Topol The influence of peripheral arterial disease on outcomes. A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials J Am Coll Cardiol 48 2006 1567 1572
42. E Nikolsky R Mehran GS Mintz GD Dangas AJ Lansky ED Aymong M Negoita M Fahy I Moussa GS Roubin JW Moses GW Stone MB Leon Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions J Endovasc Ther 11 2004 60 70